Celsus Therapeutics Announces Upcoming Presentation at Oppenheimer 25th Annual Healthcare Conference

NEW YORK and LONDON, December 2, 2014

Celsus Therapeutics (NASDAQ: CLTX), an emerging growth, development-stage biopharmaceutical company, announces that Gur Roshwalb, MD, chief executive officer, is scheduled to present at the Oppenheimer 25th Annual Healthcare Conference at Crowne Plaza Hotel in New York City.

 

Click here for the full press release